Dr Nicola Robertson
MBCHB, MRCS, FRCR
Dr Nicola Robertson trained for several years in surgery before embarking on a career in radiology. Dr Robertson was awarded two international fellowships during her radiology training, and spent 9 months at Memorial Sloan Kettering Hospital in New York City, (USA), and 12 months at St Paul’s Hospital in Vancouver (Canada), where she undertook specialist training in musculoskeletal radiology. During this time, Dr Robertson presented work at international conferences, and had multiple papers published in peer-reviewed journals. Dr Robertson continues to collaborate with colleagues in both the USA and Canada.
Dr Robertson works closely with orthopaedic surgeons and rheumatologists to diagnose and treat a wide range of musculoskeletal pathology. She regularly performs a wide range of image guided musculoskeletal interventional procedures and injections.
Dr Robertson lives in London and is a sports enthusiast, giving her first-hand experience of musculoskeletal injury!
Royal Free Hospital, Hadley Wood Hospital
Country of qualification
- British Society of Skeletal Radiology
- Society of Skeletal Radiology
All musculoskeletal diagnostics and intervention
Dr Robertson has a specialist interest in sports imaging, rheumatologic imaging and sarcoma. During Dr Robertson’s musculoskeletal fellowship, she was exposed to a wide volume and variety of cases. She attended the weekly regional sarcoma multi-disciplinary meeting, and the monthly regional sports medicine multi-disciplinary meeting.
Following a 3-month scholarship at Memorial Sloan Kettering Cancer Centre, New York City (USA), in 2014, Dr Robertson was awarded a Clinical Fellowship position, and was subsequently appointed Chief Research Fellow. During the fellowship period, Dr Robertson coordinated 4 research projects, and had multiple papers published in international peer-reviewed journals. In 2010/2011, Dr Robertson worked at UCL and University College Hospital London with Professor Mark Emberton (Professor of Interventional Oncology, Divisional Director). During this time Dr Robertson coordinated two clinical trials:
- MAPPED (MRI in Primary Prostate cancer after Exposure to Dutasteride 0.5mg)
- A European Randomised Phase 3 study to assess the Efficacy and Safety of TOOKAD Soluble for Localised Prostate Cancer Compared to Active Surveillance